Dogwood Therapeutics Files 8-K Reporting Q2 2026 Results

What Happened Dogwood Therapeutics, Inc. (DWTX) filed a Form 8-K on August 13, 2026 (Item 2.02) announcing its results of operations for the quarter ended June 30, 2026. The company furnished a press release dated August 13, 2026 reporting its second-quarter results; that press release is included as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: August 13, 2026; reporting period: quarter ended June 30, 2026.
• Item 2.02: Results of Operations and Financial Condition — press release announcing Q2 2026 results.
• Exhibit 99.1: Press release dated August 13, 2026 was furnished with the filing.
• Form signed by Angela Walsh, Chief Financial Officer, Corporate Secretary and Treasurer.

Why It Matters This 8-K notifies investors that Dogwood has publicly reported its quarterly operating results and made them available via a company press release. Investors should review the attached press release (Exhibit 99.1) and any subsequent filings for the specific financial figures, trends, or guidance that could affect valuation or near-term expectations for the company.